Vext Science Current Valuation vs. Return On Asset
| VEXTF Stock | USD 0.14 0.01 7.69% |
For Vext Science profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Vext Science to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Vext Science utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Vext Science's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Vext Science over time as well as its relative position and ranking within its peers.
Vext |
Vext Science Return On Asset vs. Current Valuation Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Vext Science's current stock value. Our valuation model uses many indicators to compare Vext Science value to that of its competitors to determine the firm's financial worth. Vext Science is rated below average in current valuation category among its peers. It is rated second in return on asset category among its peers . The ratio of Current Valuation to Return On Asset for Vext Science is about 395,416,412 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Vext Science's earnings, one of the primary drivers of an investment's value.Vext Current Valuation vs. Competition
Vext Science is rated below average in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Drug Manufacturers—Specialty & Generic industry is at this time estimated at about 2.67 Billion. Vext Science claims roughly 28.43 Million in current valuation contributing just under 2% to equities under Drug Manufacturers—Specialty & Generic industry.
Vext Return On Asset vs. Current Valuation
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Vext Science |
| = | 28.43 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Vext Science |
| = | 0.0719 |
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Vext Return On Asset Comparison
Vext Science is currently under evaluation in return on asset category among its peers.
Vext Science Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Vext Science, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Vext Science will eventually generate negative long term returns. The profitability progress is the general direction of Vext Science's change in net profit over the period of time. It can combine multiple indicators of Vext Science, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Vext Science, Inc., through its subsidiaries, operates as an integrated agricultural technology, services, and property management company in the cannabis industry in the United States. Vext Science, Inc. was incorporated in 2015 and is headquartered in Phoenix, Arizona . Vext Science is traded on OTC Exchange in the United States.
Vext Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Vext Science. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Vext Science position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Vext Science's important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in Vext Science without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Suggestion Now
Portfolio SuggestionGet suggestions outside of your existing asset allocation including your own model portfolios |
| All Next | Launch Module |
Use Investing Themes to Complement your Vext Science position
In addition to having Vext Science in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Heavy Metals Thematic Idea Now
Heavy Metals
Companies involved in mining, production, and distribution of various industrial metals and minerals. The Heavy Metals theme has 38 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Heavy Metals Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Vext OTC Stock
To fully project Vext Science's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Vext Science at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Vext Science's income statement, its balance sheet, and the statement of cash flows.